Page last updated: 2024-10-30

methazolamide and Breast Neoplasms

methazolamide has been researched along with Breast Neoplasms in 2 studies

Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"A 54-year-old female patient who had been undergoing anti-cancer chemotherapy and radiotherapy for seven years after surgery for left breast cancer visited our clinic for visual disturbance in the right eye at nine months after paclitaxel administration."3.78A case of paclitaxel-induced maculopathy treated with methazolamide. ( Kim, YC; Koo, NK, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morsy, SM1
Badawi, AM1
Cecchi, A1
Scozzafava, A1
Supuran, CT1
Koo, NK1
Kim, YC1

Other Studies

2 other studies available for methazolamide and Breast Neoplasms

ArticleYear
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
    Journal of enzyme inhibition and medicinal chemistry, 2009, Volume: 24, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Colonic

2009
A case of paclitaxel-induced maculopathy treated with methazolamide.
    Korean journal of ophthalmology : KJO, 2012, Volume: 26, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Diuretics; Female; Humans; Macular Edema; Metha

2012